SBIR-STTR Award

  1. You are here:    Home
  2. Search Databases
  3. Search SBIR-STTR Awards
  4. SBIR-STTR Award

The Goal of the Proposed Project Is to Develop an HIV Vaccine Platform for Delivery of HIV ENV Immunogen that Presents Antigen as Native Conformation
Award last edited on: 3/22/2023

Sponsored Program
SBIR
Awarding Agency
NIH : NIAID
Total Award Amount
$300,000
Award Phase
1
Solicitation Topic Code
101
Principal Investigator
Frank Y Tung

Company Information

GeneCure LLC

3150 Corners North Court
Norcross, GA 30071
   (770) 263-7508
   info@genecure.com
   www.genecure.com
Location: Single
Congr. District: 07
County: Gwinnett

Phase I

Contract Number: 75N93022C00013
Start Date: 7/1/2022    Completed: 6/30/2023
Phase I year
2022
Phase I Amount
$300,000
Novel Platforms for Delivery and/or Expression of HIV Env Immunogens for HIV Vaccines: Efforts towards the development of an efficacious HIV vaccine have focused on improvements in the design of the HIV envelope (Env) immunogen for induction and generation of broadly neutralizing antibody (bNAb) responses and novel platforms for immunogen delivery. The goal of this program is to develop an HIV vaccine platform for delivery of HIV Env immunogens that induce bnAbs and to demonstrate that the vaccine platform/immunogen proposed will elicit a strong and durable NAb HIV Env response.

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----